Optimizing sample size of a phase III trial with Simulx using a phase II popPD model

Authors: Magnard C
Conference: SLP MIDD+
Software: Monolix®, Simulx®
Division: Lixoft

Goal: design of a bridging study

Reference asthma treatment

  • Current standard-of-care
  • Approved globally (also in China)

New asthma treatment

  • FDA approved
  • does not include Chinese patients

By Claude Magnard

Download Slides

Presented at SLP MIDD+ Virtual Conference March 3-4, 2021